ABSTRACT

Postmenopausal syndrome affects a significant number of women in India. Hormonal therapies include estrogen-containing therapies, selective estrogen receptor modulators, and other compounds that mimic the effects of estrogen. The most severe risk factors relevant to pharmacological selection involve hormone replacement therapies, where concern for venous thrombosis, coronary artery disease, breast, and uterine cancer exist. These therapeutics are limited primarily by their adverse effects. Lifestyle modifications such as supplementation and physical activity may also contribute to the prevention of symptoms and are used as adjuncts to therapy following diagnosis. Methodology- A 52-year-old woman presented in the OPD of Parul Ayurved Hospital, with the complaints of Absence of menses for 16 months, hot flushes, knee joint pain, disturbed sleep, anxiety, dry vagina, fatigue and depressive mood since one year. Patient was assessed before and after treatment and she was successfully treated with Sthanik Chikitsa and oral medication. Conclusion- In Ayurveda treatment regimens can be tailored based on constitution (Prakriti) of individual as well as symptoms demonstrated by the patients, adverse effects, and clinical response to treatment. Sthanik Chikitsa has shown promising results in the management of symptoms associated with osteoarthritis, depressive mood and gynecological symptoms. Keywords: Ayurveda, menopause rating scale, postmenopausal syndrome, Rajonivritti, Sthanik Chikitsa
Publication date: 01/11/2024

https://ijbpas.com/pdf/2024/November/MS_IJBPAS_2024_8466.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.11.8466